Satellos Bioscience Inc.: Satellos Bioscience Announces 2021 Year End Financial Results and Operational Highlights

Toronto, Ontario--(Newsfile Corp. - April 29, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change

Related Keywords

United States ,Sherbrooke ,Quebec ,Canada ,Toronto ,Ontario ,Canadian ,Christina Cameron ,Ryan Mitchell ,J Robert Hall ,Adam Mostafa ,Michael Rudnicki ,John Holyoake ,Frank Gleeson ,Development Agreement ,Amphotericinb Technologies Inc ,Insights In Research Investor Summit ,Nw Pharmatech Limited ,Newsfile Corp ,Regulatory Services Provider ,Ico Therapeutics Inc ,Satellos Co ,Ampb Technologies Inc ,Satellos Bioscience Inc ,Vico Therapeutics ,Venture Exchange ,Co To Satellos Bioscience Inc ,Business Development ,Satellos Co Founder ,Canada Business Corporations ,Parent Project Muscular Dystrophy ,Defeat Duchenne Canada ,Rima Al Awar ,Chief Scientific Officer ,Research Investor Summit ,Scientific Conference ,Drug Discovery News ,Ampb Tech ,Oral Ampb Delivery System ,Joint Development Agreement ,Tech Limited ,Joint Venture ,For Distribution ,Satellos ,Ioscience ,Nnounces ,021 ,Ear ,Financial ,Results ,Perational ,Highlights ,